Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2 (Q24607986)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
scientific article

    Statements

    Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2 (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit